Frequency of triggering bacteria in patients with reactive arthritis and undifferentiated oligoarthritis and the relative importance of the tests used for diagnosis
Open Access
- 1 April 2001
- journal article
- other
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 60 (4) , 337-343
- https://doi.org/10.1136/ard.60.4.337
Abstract
OBJECTIVE Reactive arthritis (ReA) triggered by Chlamydia trachomatis or enteric bacteria such as yersinia, salmonella,Campylobacter jejuni, or shigella is an important differential diagnosis in patients presenting with the clinical picture of an undifferentiated oligoarthritis (UOA). This study was undertaken to evaluate the best diagnostic approach. PATIENTS AND METHODS 52 patients with ReA, defined by arthritis and a symptomatic preceding infection of the gut or the urogenital tract, and 74 patients with possible ReA, defined by oligoarthritis without a preceding symptomatic infection and after exclusion of other diagnoses (UOA), were studied. The following diagnostic tests were applied for the identification of the triggering bacterium: for yersinia induced ReA—stool culture, enzyme immunoassay (EIA), and Widal's agglutination test for detection of antibodies to yersinia; for salmonella or campylobacter induced ReA—stool culture, EIA for the detection of antibodies to salmonella andCampylobacter jejuni; for infections with shigella—stool culture; for infections withChlamydia trachomatis—culture of the urogenital tract, microimmunofluorescence and immunoperoxidase assay for the detection of antibodies to Chlamydia trachomatis. RESULTS A causative pathogen was identified in 29/52 (56%) of all patients with ReA. In 17 (52%) of the patients with enteric ReA one of the enteric bacteria was identified: salmonella in 11/33 (33%) and yersinia in 6/33 (18%).Chlamydia trachomatis was the causative pathogen in 12/19 (63%) of the patients with urogenic ReA. In patients with the clinical picture of UOA a specific triggering bacterium was also identified in 35/74 (47%) patients: yersinia in 14/74 (19%), salmonella in 9/74 (12%), and Chlamydia trachomatis in 12/74 (16%). CONCLUSIONS Chlamydia trachomatis, yersinia, and salmonella can be identified as the causative pathogen in about 50% of patients with probable or possible ReA if the appropriate tests are used.Keywords
This publication has 47 references indexed in Scilit:
- Reactive arthritisCurrent Opinion in Rheumatology, 1999
- High frequency ofYersinia antibodies in healthy populations in Finland and GermanyRheumatology International, 1997
- THE VALUE OF ISOTYPE DETERMINATION OF SERUM ANTIBODIES AGAINST CHLAMYDIA FOR THE DIAGNOSIS OF CHLAMYDIA REACTIVE ARTHRITISRheumatology, 1996
- Yersinia-specific antibodies in serum and synovial fluid in patients with Yersinia triggered reactive arthritis.Annals of the Rheumatic Diseases, 1994
- Salmonella-triggered reactive arthritisThe Lancet, 1992
- Occurrence of different ensuing triggering infections preceding reactive arthritis: a follow up studyBMJ, 1988
- Serum specific IgA antibody to Chlamydia trachomatis in patients with chlamydial infections detected by ELISA and an immunofluorescence test.Journal of Clinical Pathology, 1984
- ELISA and RIA for Serologic Diagnosis of YersiniosisClinical Infectious Diseases, 1984
- Reiter's syndrome and reactive arthritisClinical Rheumatology, 1983
- Evidence of Chlamydia trachomatis infection in sexually acquired reactive arthritis.Annals of the Rheumatic Diseases, 1980